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Calreticulin (CRT), an intracellular chaperone protein crucial for the proper folding and transport of proteins
through the endoplasmic reticulum, has more recent acclaim as a critical regulator of extracellular functions,
particularly in mediating cellular migration and as a requirement for phagocytosis of apoptotic cells. Consistent
with these functions, we show that the topical application of CRT has profound effects on the process of wound
healing by causing a dose-dependent increase in epithelial migration and granulation tissue formation in both
murine and porcine normal and impaired animal models of skin injury. These effects of CRT are substantiated,
in vitro, as we show that CRT strongly induces cell migration/wound closure of human keratinocytes and
fibroblasts, using a wound/scratch plate assay, and stimulates cellular proliferation of human keratinocytes,
fibroblasts, and vascular endothelial cells, providing mechanistic insight into how CRT functions in repair.
Similarly, in both animal models, the histology of the wounds show marked proliferation of basal keratinocytes
and dermal fibroblasts, dense cellularity of the dermis with notably increased numbers of macrophages and
well-organized collagen fibril deposition. Thus, CRT profoundly affects the wound healing process by recruiting
cells essential for repair into the wound, stimulating cell growth, and increasing extracellular matrix production.
Journal of Investigative Dermatology Symposium Proceedings (2006) 11, 57–65. doi:10.1038/sj.jidsymp.5650011
OVERVIEW OF CALRETICULIN INTRACELLULAR AND
EXTRACELLULAR FUNCTIONS
Calreticulin (CRT), a Ca-binding protein, provides the
important function of chaperoning glycoproteins through
the endoplasmic reticulum (ER), ensuring proper protein
folding and preventing aggregation (Krause and Michalak,
1997; Johnson et al., 2001; Bedard et al., 2005). A lectin site
on CRT recognizes N-linked oligosaccharide processing
intermediates of glycoproteins and prolonged interaction
with misfolded proteins initiates rejection and subsequent
direction to the proteasome for degradation. CRT also
engages in direct protein–protein interactions. Another major
function of CRT is to maintain intracellular calcium home-
ostasis (Arnaudeau et al., 2002), important in signaling,
particularly of integrins, which require calcium for protein
interactions and functions. In this regard, CRT specifically
chaperones alpha integrins through the ER and the binding of
CRT to their cytoplasmic domains is tightly regulated by
intracellular calcium levels required for integrin signaling,
important in regulating cell shape, adhesion, spreading, and
motility (Coppolino et al., 1997; Kwon et al., 2000).
Transcriptional activation of the CRT gene, itself, is regulated
by the modulation of cytosolic calcium concentration (Krause
and Michalak, 1997). In addition, CRT has been shown to
affect cell adhesion through calmodulin and calcium-
mediated kinase (Bedard et al., 2005). As the ER is contiguous
with the nuclear membrane, which also stores calcium, CRT
has been shown to be involved in nuclear functions including
gene transcription and nucleocytoplasmic transport, particu-
larly of p53 and myocyte enhancer factor-2 (Lynch et al.,
2005), associated with a decrease in apoptosis (Ashby and
Tepikin, 2001). Interestingly, CRT directly binds to the
identical amino-acid sequence, GFFKR, in the alpha integrin
cytoplasmic tails as in the DNA-binding region of many
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steroid receptors, to inhibit steroid-sensitive gene activation,
as a major nuclear function of this protein (Burns et al., 1994a,b;
Dedhar, 1994; Dedhar et al., 1994; Michalak et al., 1996).
CRT is a ubiquitous cellular protein and its importance in
cell function is underscored by the fact that CRT cDNA is
conserved in most organisms, that there is 90% amino-acid
homology among mammals, and that CRT null mice die mid-
gestation, notably with severe cardiac abnormalities (Mesaeli
et al., 1999; Rauch et al., 2000; Johnson et al., 2001). CRT is
a 46 kDa glycoprotein that is divided into three domains,
preceded by an amino-terminal hydrophobic (ER) signal
sequence. The P-domain contains the lectin site and a high-
affinity Ca-binding region. The acidic carboxy-terminal C-
domain contains the high-capacity, low-affinity Ca2þ ,
binding sequence and terminates in a KDEL (lysine, aspartic
acid, glutamic acid, leucine) sequence for ER retrieval
(Krause and Michalak, 1997; Bedard et al., 2005). Most
recently, for the first time, CRT was shown to exist outside the
ER by retrotranslocation to the cytoplasm (Afshar et al.,
2005). However, despite a major effort to determine how
CRT is transported out of the cell, to date, this mystery has not
been solved. Although CRT has been found in the Golgi and
may exit the cell passively by binding to other proteins, this is
still only speculative. Nonetheless, a multitude of extracel-
lular functions have been ascribed to CRT and it has been
localized to the cell surface of many mammalian cell types
(Johnson et al., 2001; Bedard et al., 2005).
The overexpression of CRT causes an increase in
fibronectin and cell spreading as well as an upregulation of
the cytoskeletal protein, vinculin (mRNA and protein), in
focal adhesion contacts, all contributing to increased adhe-
sion. Whereas the adhesion function is believed to be
regulated by CRT from within the ER (Opas et al., 1996),
other functions important in both migration and phagocy-
tosis, hinge on staunchly supported evidence for extracellular
functions of CRT (Goicoechea et al., 2000, 2002; Murphy-
Ullrich, 2001; Orr et al., 2002, 2003a, b; Gardai et al., 2005).
In fact, CRT is considered to be a cell surface receptor for
thrombspondin-1 (TSP-1) on bovine arterial endothelial cells
(Goicoechea et al., 2000) and for complement component
C1q (McGreal and Gasque, 2002; Ghiran et al., 2003).
Further, cell surface CRT binds to the carbohydrate consti-
tuent (mannose) of the cell adhesion and basement mem-
brane protein, laminin, important in cell migration through
integrin binding (White et al., 1995; McDonnell et al., 1996).
Importantly, a series of studies has shown that cell surface
CRT interacts with the heparin-binding domain I of TSP-1 to
mediate focal adhesion disassembly, for migration. The
binding site in the N-terminus of CRT that binds heparin-
binding domain I, to mediate TSP-1 signaling, has been
localized to amino-acid residues 19–36, and accordingly, this
peptide blocks focal adhesion disassembly in fibroblasts and
endothelial cells (Goicoechea et al., 2002). Phosphatidy-
linositol 3-kinase is activated during the interaction of CRT
with TSP as well as guanine nucleotide protein and
extracellular signal-regulated kinase (phosphorylation) path-
ways to promote the cytoskeletal changes associated with this
process of de-adhesion. This is termed an ‘‘intermediate
adhesive state’’ that aids in the ability of cells to respond to
microenvironmental stimuli (Murphy-Ullrich, 2001; Orr
et al., 2002, 2003a). CRT null mouse embryo fibroblasts do
not respond to TSP-1/heparin-binding domain I, but can be
rescued with exogenous CRT (Goicoechea et al., 2002). As
cell surface CRT, as a receptor lacks a transmembrane domain,
a search for a co-receptor that might mediate its action
revealed an interaction between CRT and the ‘‘promiscuous’’
low-density lipoprotein receptor-related protein (LRP/cluster
domain (CD)91/a2-macroglobulin) (Orr et al., 2003a). Finally,
the role for the TSP-1/CRT/LRP receptor in complex-induced
focal adhesion disassembly, as a component necessary for cell
migration, was elegantly illustrated using both CRT and LRP
null mouse embryo fibroblasts that failed to migrate in
response to TSP-1 (Orr et al., 2003a).
LRP interacts with CRT on the same cell (cis-interaction) to
enable cellular migration. Most recently, it has been shown
that the LRP on phagocytic cells is activated by interacting
with CRT and phosphotidylserine on the surface of apoptotic
cells (trans-interaction), as a default signal for their engulf-
ment by both professional and non-professional phagocytes,
such as fibroblasts (Gardai et al., 2005). This discovery of
CRT as a ‘‘universal’’ mediator of apoptotic cell clearance
was prompted by CRT-deficient dead cells that were not
phagocytosed by macrophages without the addition of
exogenously supplied CRT. In these studies, the activation
of LRP by soluble CRT stimulates micropinocytosis, activates
rac-1, and induces the engulfment of cells passively bound by
the phagocyte. Although CRT is on the surface of both live
and dead cells, the presence of CD47 (integrin-associated
protein (IAP)) blocks the uptake of live cells by phagocytes.
Therefore, the downregulation of CD47 is essential for CRT to
activate LRP on the phagocyte to signal uptake of dead cells,
and accordingly, live cells are engulfed by simply blocking
CD47. This function of CRT has obvious beneficial applica-
tion in wound healing for debriding injured tissue and studies
are underway to determine whether CRT may, in addition, be
required or at least enhance the clearance of bacterial
contaminants of the wound bed. As another function, CRT
has been shown to exert a protective effect on damaged
blood vessels through the C-domain (Johnson et al., 2001).
Therefore, one can ascertain that these extracellular activities
are consistent with a role for CRT in wound repair, and
importantly, provide mechanistic insight of its action in this
process.
CHARACTERIZATION OF CRT AS THE ACTIVE
COMPONENT IN WOUND HEALING OF A
HYALURONAN-RICH ISOLATE FROM FETAL SHEEP SKIN
With the background knowledge of CRT, predominantly as
an intracellular protein with no evidence for secretion, our
rationale for the use of this protein in wound healing studies
deserves explanation. In previous studies, it was shown that
hyaluronic acid (HA) isolated from fetal sheep accelerated
repair in a rat animal model. However, the beneficial effects
were obviated by heat and protease treatment but not by
hyaluronidase (Burd et al., 1991). The active protein was
termed hyaluronan protein complex (HA-PC) (Bakshandeh
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et al., 1992; Cabrera et al., 1995), and subsequently,
following purification and amino-acid sequencing, the active
protein component of the HA isolate was determined to be
CRT. In the following wound healing studies described
herein, a recombinant his-tagged protein produced in E. coli
(Baksh et al., 1992), as described, was used. Our approach
involved the use of murine and porcine models of wound
repair as well as in vitro studies that investigated the effects of
CRT on proliferation and migration of human keratinocytes
and fibroblasts. As this overview is a report from a meeting
presentation, the experimental detail will be described
briefly.
CRT INCREASES THE RATE AND QUALITY OF WOUND
HEALING IN VIVO
Although loose-skinned hairy animals such as rodents offer
good animal model systems to study wound healing for many
reasons, including large trial numbers, they do not heal like
humans as the panniculus carnosus muscle directly below the
skin causes contraction preventing the evaluation of wound
resurfacing or re-epithelialization. In contrast, pigs heal more
like humans for many reasons including healing by epithelial
migration over the wound bed, the concentration of hair
follicles, and the presence of sweat glands (Bennett et al.,
2001; Sullivan et al., 2001). Therefore, we chose to
determine the effects of CRT on wound healing in both
animal models, comparing the effects of CRT with the
positive controls, vascular endothelial cell growth factor
(VEGF), an angiogenic growth factor and platelet-derived
growth factor (PDGF; BB chain), a growth factor for
fibroblasts and endothelial cells (in a formulation/vehicle
known as Becaplermin or Regranex gel) (Embil et al., 2000;
Nagai and Embil, 2002), in the murine and porcine models,
respectively. Both factors have beneficial effects on wound
repair by (only) targeting the dermis through increasing
granulation tissue formation (Embil et al., 2000; Nagai and
Embil, 2002; Galiano et al., 2004b; Michaels et al., 2005).
The extent of granulation tissue formation results from
recruitment of cells into a wound, proliferation of the cells
that inhabit the newly forming dermis, and production of
extracellular matrix proteins by the composite cells. Re-
epithelialization of the wounds, resulting from epithelial
migration, is aided by an abundant provisional matrix/
granulation tissue. As CRT is a calcium-binding protein, we
reasoned that the appropriate conformation of the molecule
for biological activity might require calcium. Wounds treated
with CRT in buffer (10 mM Tris) without or with calcium
(3.0 mM) showed no statistically significant difference in any
parameters measured for healing. Therefore, the data
reported herein used buffers containing calcium. The proto-
cols for both the murine and porcine studies were approved
by the Institutional Animal and Use Committee (IACUC) of
New York University School of Medicine and Vanderbilt
University Medical Center, respectively.
Murine studies
An increased effect on wound healing by any agent has rarely
been observed in the normal mouse. Therefore, we used 8 to
12-week-old db/db mice (BKS.Cg-mþ /leprdb; leptin receptor-
deficient model of type II diabetes mellitus) that have
impaired wound healing (Coleman, 1982). Normal C57BL/
6J mice of the same age were also tested. A novel improved
method that more closely simulates human healing by
minimizing wound contraction in the mouse was used, as
described (Galiano et al., 2004a). Briefly, a circular donut-
shaped splint centered (shown as orange surrounding the
wound in Figure 1) over the wound permits healing by
epithelial migration over the newly produced provisional
matrix to close the wound gap. The splint allows direct
application of the CRT and visibility for digital photographs
used to measure wound closure. CRT at 1.0 and 5.0 mg/ml in
10 mM Tris containing 3 mM Ca, buffer alone, phosphate-
buffered saline, and VEGF (1.0 mg/ml) in a volume of 0.01 ml
were separately applied to two 5-mm-diameter full-thickness
excisional wounds at the onset of wounding and everyday
thereafter for 4 days (Galiano et al., 2004b; Michaels et al.,
2005). The wounds were measured daily and days to full
closure determined. Time to closure is defined as the time
(day) the wound bed is completely closed/filled and epithelial
gap is defined as the area of the wound uncovered by
migrating epithelia (note: a wound is re-epithelialized before
it is completely closed). The closure of the wounds, epithelial
gap, and granulation tissue (newly formed dermis) were
measured morphometrically and the analysis of wound
measurements and statistics were performed, as described
(Michaels et al., 2005). To measure cell proliferation in vivo,
mice were injected with bromodeoxyuridine at 4 hours
before harvesting the wounds. As expected, there was no
difference in any parameters of healing measured among
CRT, buffer, or VEGF treatments in normal mice. However,
using the db/db impaired model of wound repair, the CRT
(5.0 mg/ml)-treated wounds showed a statistically significant
difference in the extent of wound closure, measured as
percent of the original size, from day 14 onwards, compared
to control wounds, as shown in Table 1. The CRT-treated
CRT Buffer
Figure 1. Comparison of gross wound closure in a (left) CRT
(5.0 mg/ml)-treated mouse wounds versus (right) buffer control at day 14.
Wounding of db/db mice is described in the text. The orange background
surrounding the wound depicts the silicon splint centered over the 5.0 mm
diameter full-thickness excisional wound to prevent wound contraction.
CRT is diluted in buffer containing 10 mM Tris, 3 mM Ca (pH 7.0). Wound
closure is shown to be greater in the CRT-treated wound (Pp0.05).
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mice showed average complete wound closure at 17.60 days
post-wounding compared to the control wounds with an
average of 23.2 days to closure (Pp0.045; n¼ 5 at each time
point). Figure 1 shows a representative comparison between
a CRT and buffer-treated wound at 14 days post-wounding.
Similarly, CRT induced a statistically significant difference in
extent of epithelial migration over the wound (epithelial gap
measurements) at day 7 (Pp0.039; n¼ 6), but not at day 3
post-injury (n¼ 6); by day 14, the epithelial gaps were closed.
Furthermore, CRT induced a greater area of granulation tissue
beneath the wounds, which was statistically significant at the
higher dose at day 7 post-wounding in one set of experiments
(Table 2; Pp0.001; n¼9 wounds) and at day 14 in another
set of experiments.
Using picrosirius red staining for collagen, Figure 2 shows
the dose-dependent increase in granulation tissue at 1.0 and
5.0 mg/ml compared to the buffer control and VEGF (descri-
bed below). Whereas these experiments are preliminary (unpub-
lished) and ongoing, the data show that CRT, using 200mg/
mouse, over 4 days, showed positive effects on improving
both the rate and quality of wound healing in an impaired
murine model. The results using VEGF have been reported
elsewhere (Galiano et al., 2004b; Michaels et al., 2005).
These results suggest potential effects of CRT on migration
and proliferation of cells involved in repair of the damaged
epidermis and dermis in a diabetic wound healing model.
Porcine studies
These studies were performed on six Yorkshire pigs; three
normal and three rendered steroid impaired by injection of
methylprednisolone 2 days before wounding. Four long-
itudinal partial thickness wounds, removing only part of the
dermis (1560mm deep) separated by pieces of intact skin
secured with sutures (as bridges between wounds) were
created on the dorsum of the pigs, as described (Bennett
et al., 2001). The wounds were treated with CRT (1.0–5.0 mg/
ml), buffer, or Regranex (0.01%) at the onset of wounding,
and then treated for three more successive days (CRT: 100
and 500 mg total per pig). Wounds for harvesting at 10 days
(eight wounds) were made first and another set (eight
wounds) was made 5 days later. In the normal pigs, re-
epithelialization was complete by 7 days post-wounding. As
in the human, keratinocytes that re-epithelialize the wounds
migrate from both the wound margins and hair follicles,
creating islands of epithelialized surface. The total coverage
of the wound resulting from both epithelial migration and
proliferation was quantitated morphometrically (Image Pro
Plus) and expressed as percent healed. Data were expressed
as mean7SE and statistical significance was determined by
analysis of variance and Bonferroni’s post hoc test. Short of
reaching statistical significance, at day 5 after wounding, the
CRT-treated wounds appeared more mature showing greater
stratification compared to Regranex (percent healed: 1.0 mg/
ml CRT¼ 58% versus Regranex¼40%). Importantly,
whereas the CRT-treated wounds were completely resurfaced
by 10 days, the Regranex-treated wounds were not re-
epithelialized at this time point (n¼6 wounds per category).
Granulation tissue formation, measured morphometrically as
dermal depth (distance between the newly formed dermis,
from the junction of the epidermis extending to the dermis
that was left unwounded), showed a statistically significant
increase in the CRT (5.0 mg/ml)-treated wounds compared to
Regranex at 5 days post-wounding (Pp0.04; n¼ 6). More-
over, a dose response in the CRT-treated wounds (1.0 versus
5.0 mg/ml) was obtained indicating the specificity of the
response (Pp0.058; n¼6). It was noted that the steroid-
impaired pigs showed varied inherent differences in healing.
Table 1. Days to closure
Buffer CRT
Day 0 1.0070.00 1.0070.00 —
Day 2 0.9570.04 0.8970.08 —
Day 4 0.8670.08 0.7670.07 —
Day 6 0.7470.05 0.6570.09 —
Day 8 0.6170.03 0.5170.08 —
Day 10 0.4770.10 0.3870.20 —
Day 12 0.4370.09 0.2770.17 —
Day 14 0.3270.22 0.1170.10 *Po0.05
Day 16 0.2970.22 0.0670.06 *Po0.05
Day 18 0.2670.21 0.0370.04 *Po0.05
Day 20 0.2270.21 0.0070.00 *Po0.05
Day 22 0.2170.20 0.0070.00 *Po0.05
Day 24 0.0470.06 0.0070.00 —
Day 26 0.0070.00 0.0070.00 —
CRT=Calreticulin.
Kinetics of wound closure in CRT (5.0 mg/ml)-treated wounds versus
buffer controls. Mouse wounds were photographed every other day and
open areas were calculated morphometrically, as described (Galiano
et al., 2004a; Michaels et al., 2005). The data represent the mean of the
percent remaining open compared to the area of the original wound
size7SE (area at day 0=100%) of wounds db/db mice. Differences in
average wound size between the groups was statistically significant
(Po0.05) from days 14 to 22. The average time for complete wound
closure in the CRT-treated wounds was 17.60 compared to 23.2 days in
the buffer-treated controls (Pp0.045, n=5 at each time point). A two-
tailed Student’s t-test was used to compute the P-value.
Table 2. Depth of granulation tissue
Buffer CRT
Day 3 25,92278,591 82,115758,772
Day 7* 29,20875,566 50,74279,272
Day 14 60,19972,3982 97,269763,817
CRT=Calreticulin.
*Po0.001.
Granulation tissue formation in CRT (5.0 mg/ml)-treated wounds versus
buffer controls. Wounds were harvested at days 3, 7, and 14 and 5.0mm
histological sections were photographed and analyzed using morpho-
metric software, as described (Michaels et al., 2005). Data represent the
mean number of pixels7SE of granulation tissue present in wounds from
between three and nine db/db mice for each day and treatment parameter.
The increased amount of granulation tissue formation in CRT-treated
wounds was statistically significant on day 7 (Po0.001). A two-tailed
Student’s t-test was used to compute the P-value.
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The differences in percent healed and depth of granulation
tissue of these wounds harvested at 6 days post-wounding
was unremarkable (n¼ 6–8 per category), except a more
dense/compacted granulation tissue was noted in the CRT-
treated wounds, possibly indicating that these wounds were
more mature.
Both the murine and porcine studies provided evidence
that CRT had positive effects on wound healing equal to or
better than the chosen positive controls. However, the
histology of the wounds showed remarkably unique chara-
cteristics in the CRT-treated wounds indicative of a more
profound effect on wound healing.
HISTOLOGICAL ANALYSES OF THE WOUNDS
IMPLICATE MARKED BIOLOGICAL EFFECTS OF
CRT ON WOUND HEALING
The histology of the wounds was highly impressive, and
importantly, the murine and porcine models showed similar
unique characteristics in the CRT-treated wounds. Evidence
for a strong effect and dose-dependent effect of CRT on both
the epidermis and dermis consistent with improved wound
repair compared to the negative controls was shown in both
animal models. Furthermore, as described below, CRT induced
markedly different effects on aspects of wound healing and,
particularly, in cells involved in remodeling compared to the
positive controls, VEGF (mouse) and PDGF (pig).
CRT strongly and dose-dependently induces cellular
proliferation in basal keratinocytes and dermal cells
The hematoxylin–-eosin-stained wounds revealed a dose-
dependent increase in cellularity in the remodeling wound
bed in the CRT-treated murine wounds, particularly on days
3–14, which was greater than the VEGF-treated wounds. This
high degree of cellularity was contributed by a higher rate of
proliferation of the cells of the entire wound bed observed
following immunostaining for bromodeoxyuridine in wounds
harvested at 3 days post-wounding.
This greatly increased cellularity of the dermis was also
shown in the normal and impaired CRT-treated porcine
wounds. Interestingly, there was a unique dose-dependent
increase in kinetichore nuclear protein 67 (marker of
proliferation) immunostaining that was localized to the nearly
all basal and some suprabasal keratinocytes in both the
normal porcine wounds, at 5 days, when an epithelial gap
still remained open, and in the closed steroid-treated pigs at 7
days post-wounding. This specific pattern of kinetichore
nuclear protein 67-positive cells was also observed in the
unclosed murine wounds examined at 7 days after wounding.
Moreover, there were many more proliferating cells in the
dermis (appeared to be fibroblasts) in both the porcine and
murine wound models treated with CRT than in either the
negative or positive controls at all time points examined. As
shown previously, the keratinocytes of the migrating epithe-
lial tongue were not kinetichore nuclear protein 67-positive,
as cells that migrate do not proliferate (Werner and Munz,
2000; Onuma et al., 2001). The strong proliferative effect of
CRT on the basal keratinocytes before and after re-epitheliza-
tion may indicate that these cells continue to be involved in
wound remodeling (Usui et al., 2005), which we show herein
is enhanced by CRT.
CRT-treated wounds had increased granulation tissue and
evenly distributed collagen compared to the positive control
A dose-dependent increase in collagen deposition that was
evenly dispersed within the highly cellular dermis as well as
an increase in the area of granulation tissue (as shown in
Buffer
CRT (1) CRT (5) CRT (1) CRT (5)
VEGF Buffer VEGF
Bright light Polarized light
Figure 2. Collagen deposition by picrosirius red staining of CRT (1.0 mg/ml; 5.0 mg/ml), VEGF (1.0 mg/ml), and buffer-treated mouse wounds at 10 days
after injury. Slides containing mouse tissue were stained with picrosirius red, as described (Noorlander et al., 2002; Cuttle et al., 2005) and examined by bright
field (left panels) and polarized light (right panels). Under polarized light, yellow-green staining denotes a more-organized and less crosslinked collagen
and a yellow-red hue indicates more highly crosslinked collagen. Both the panels depicting wounds, under bright field and polarized light, show a dose-
dependent increase in collagen deposition in the area of granulation tissue in the CRT-treated wounds. The yellow-green birefringence shown in the 5.0 mg/ml
(5) CRT-treated wound (lower right panel) suggests a more organized and less crosslinked collagen matrix compared to the VEGF-treated wounds (upper
right panel). The increase in granulation tissue is owing to both the abundant cellularity and matrix deposition in the CRT-treated wounds. Buffer, 0.01 M Tris,
3.0 mM calcium, (pH 7.0); CRT (1), CRT in buffer at 1.0 mg/ml; and CRT (5), CRT in buffer at 5.0 mg/ml.
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Table 2) was evident in the CRT-treated murine wounds at all
time points after 4 days by both trichrome and picrosirius red
staining (Figure 2). Picrosirius red staining provides color-
dependent information regarding collagen organization and
maturity (Noorlander et al., 2002; Cuttle et al., 2005). As
shown in Figure 2 (right panels) of wounds 10 days after
injury, both CRT (5.0 mg/ml) and VEGF induced a robust
deposition of collagen; a dose-dependent response is shown
in the CRT-treated wounds. After day 7 and through day 14
post-injury, the collagen fibrils appeared more yellow-green
in the CRT-treated wounds (bottom right panel), suggesting a
better-organized and less crosslinked collagen matrix com-
pared to a red-yellow pattern in the VEGF-treated wounds
(upper right panel), which is consistent with higher cross-
linking and potentially scarring. In addition, as a marker for
granulation tissue formation, fibronectin was increased in the
CRT-treated mouse and porcine wounds (data not shown).
The increased dermal depth of the CRT-treated wounds,
shown by both bright field (Figure 2, left) and polarized light
(Figure 2, right), is owing to both increased cellularity and
matrix deposition. The VEGF-treated wounds similarly show
abundant collagen deposition, but were not as cellular as the
CRT-treated wounds (not obvious with this staining techni-
que). The possibility that CRT induced a better quality of
healing as an example of an antiscarring effect deserves
further investigation in appropriate models.
CRT uniquely induced an influx of macrophages into the
wounds
The CRT-treated porcine wounds demonstrated a deluge of
macrophages drawn into the wound bed, as determined by
immunoreactivity using MAC387 antibody. By morphometric
analysis of the non-impaired porcine wounds at 5 days after
injury, a 3-fold increase in the total number of macrophages
was observed throughout the wounds treated with both 1.0
and 5.0 mg/ml CRT compared to the control or Regranex
(Pp0.008; n¼6–8). Interestingly, 50% more macrophages
appeared to remain within the microvascular structures of the
dermis than in the extracellular matrix. In the impaired model
of wounding, this identical pattern was observed on day 6
post-injury wounds. We have not examined the effect of CRT
on monocyte/macrophage migration in vitro. However, there
is the possibility that the effect may be indirect through CRT-
induced cytokine release by cells of the dermis including
immune cells (Okuyama et al., 2004). The uniquely interest-
ing effect of macrophages sequestered in blood vessels is not
understood at this time. Nonetheless, considering that CRT
recently has the auspicious function as the ‘‘universal’’
mediator of phagocytosis of apoptotic cells (Gardai et al.,
2005), exogenous CRT in the treated wounds may have a
2-fold function: first, to attract and/or mediate the migration
of macrophages and other phagocytes into the wound, and
subsequently, to enhance their ability to debride the wound.
CRT is dynamically expressed after skin injury and throughout
wound repair
Whether CRT plays a physiological role in wound healing
would be substantiated by its dynamic expression during the
process of skin repair after injury, which could putatively be
enhanced with therapeutic applications of the protein. Using
an antibody to CRT (from M. Michalak), similar temporal and
spatial changes in the expression of CRT were observed
during wound healing in both the porcine and murine
wounds. Briefly, CRT immunoreactivity was decreased in the
epidermis after wounding with no immunostaining in the
migrating epithelium, which in the porcine wounds was
evident in the keratinocytes migrating from the wound
margins as well as those migrating up the hair follicles to
re-epithelialize the wounds (data not shown). Interestingly,
the basal keratinocytes in both the adjacent unwounded and
wounded skin, including the hypertrophic epidermis of
completely resurfaced wounds at 10 days post-wounding,
expressed negligible amounts of CRT. As these are the same
specific cells of the epidermis that proliferated in response to
CRT, this result, although provocative, cannot be explained at
this time. Thus, as basal keratinocytes respond to CRT, but do
not appear to express the protein (or no longer detected by
the anti-CRT antibody), this point may clearly represent an
extracellular function for CRT, requiring specific receptor
activation. CRT was greatly increased in the cells of the
dermis in wounded compared to unwounded skin. Most
notably, fibroblastic-type cells showed intense cytoplasmic
immunoreactivity, and macrophages were notably highly
immunoreactive whereas unwounded skin showed little
dermal immunostaining. In light of these results, it will be
interesting to determine the functional relevance of the
expression of CRT in specific cell types in the wounds
and whether they are intracellular- or extracellular-driven
responses of CRT.
IN VITRO STUDIES RECAPITULATE THE WOUND
HISTOLOGY AND PROVIDE MECHANISTIC INSIGHT
INTO THE BIOLOGICAL EFFECTS OF CRT ON WOUND
HEALING
CRT induces migration of human keratinocytes and human and
mouse fibroblasts
Primary human keratinocytes from breast skin, kindly
supplied by Marjana Tomic (Departments of Dermatology
and Microbiology, NYU School of Medicine) and a human
low passage dermal fibroblast cell line, CCD-1070SKs (ATTC)
were used to interrogate whether epidermal and dermal cells
could migrate in response to CRT, in vitro. The scratch plate
assay is the standard and simple well-used in vitro model for
wound re-epithelialization, which tests the function of
migration, albeit, non-directed migration (Huang et al.,
1998; Lampugnani, 1999). Monolayers of keratinocytes or
fibroblasts on plastic tissue culture plates were wounded, as
described in Figure 3. The cells were treated with CRT in
3.0 mM calcium, and after 24 or 48 hours, the plates were
photographed and percent wound closure determined, as
described in Figure 3.
CRT (1–100 pg/ml) induced maximum wound closure of
keratinocytes to 15% at 10 pg/ml in 48 hours compared to
both buffer containing calcium and media, at 2% closure;
epidermal growth factor (EGF) (10 ng/ml) used as a positive
control induced 12% closure (n¼ 5). Calcium was shown to
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be required to maintain the proper conformation of CRT for
the function of inducing migration in both the fibroblasts and
keratinocytes tested in our studies. We found that the effect of
CRT, but not EGF, on keratinocyte migration was partially
inhibited in the presence of mitomycin C. Therefore, the
migration of keratinocytes in response to CRT may, in part, be
related to CRT induction of proliferation as well as migration
in keratinocytes. However, classic migration/chemotatic
assays using transwells are necessary to verify this point.
CRT induced fibroblast migration with an optimal dose of
100 ng/ml, a 10,000 times higher dose than was required for
keratinocytes. Whereas the keratinocytes appeared more
sensitive, the fibroblasts migrated at a faster rate as they
covered 23% of the wound in 24 hours compared to the
buffer at 1.5% and EGF at 36% closure (n¼ 10). The 3T3
mouse embryo fibroblast cell line was more sensitive to CRT
than the human fibroblasts as CRT induced maximal closure
of 36% at 50 pg/ml compared to 2% and 36% (after 48 hours),
in the buffer and mouse EGF control, respectively (n¼ 5;
shown in Figure 3). A true migratory response to CRT was
obtained with the fibroblasts as mitomycin C did not
modulate migration. As TSP-1-induced migration is mediated
by cell surface CRT (exogenously added or expressed by
endothelial cells and fibroblasts) and the LRP (Goicoechea
et al., 2000; Orr et al., 2002, 2003a, b; Barker et al., 2004),
we hypothesize that the cells that migrate into the wound
may utilize focal adhesion disassembly as a mechanism of
migration. Both the processes of migration and cellular
proliferation likely contribute to the highly cellular granula-
tion tissue we observed in the CRT-treated wounds. We
presume that the abundance of these cells in the granulation
tissue would positively impact the rate and quality of wound
remodeling.
CRT induces proliferation of human keratinocytes and
fibroblasts
The intense cellularity of the dermis and kinetichore nuclear
protein 67 immunostaining in the keratinocytes and cells of
the dermis suggested that CRT might directly induce cellular
proliferation. The primary keratinocytes and fibroblast cell
line described above were tested for their proliferative
response to CRT using the CellTiter 96 assay (Promega,
Madison, WI). CRT (0–200 pg/ml), diluted in buffer with or
without 3 mM calcium, added to the cells (in triplicate) under
serum-free conditions induced a 2.2-fold increase in kerati-
nocytes proliferation at a maximum dose of 100 pg/ml after
72 hours, which was decreased at 200 pg/ml, giving a typical
bell-shaped distribution (n¼ 4). For comparison, EGF (posi-
tive control; 10 ng/ml) stimulated proliferation to 1.3-fold
over the untreated control. Similarly, the fibroblasts were
induced to proliferate by CRT (0–150 ng/ml) with a maximal
response (100 ng/ml CRT), which was 8.3-fold higher than
the untreated controls (n¼4). EGF (10 ng/ml) induced a 7.8-
fold increase in proliferation. Unlike the CRT-induced
migratory/motility response in our experiments, calcium
was not required for the proliferative response. This suggests
that the Ca-dependent conformation of CRT may not be
required for proliferation and that perhaps a different domain
of the molecule may be involved. Whereas it has been shown
that fibrinogen beta chain-induced fibroblast proliferation is
mediated by cell surface CRT (Gray et al., 1995), the effect of
CRT on keratinocytes proliferation is an interesting and novel
finding, opening a new area of investigation that undoubtedly
will be relevant to many physiological processes. Potentially,
functions may include the regulation of cell cycle proteins as
CRT has been shown to function in the nucleus (Johnson
et al., 2001; Bedard et al., 2005).
CRT AS AN AGENT FOR THE IMPROVEMENT OF
(IMPAIRED) WOUND HEALING
The extent that CRT-mediated responses are directed from the
ER or mediated extracellularly including different receptors
and signaling intermediates, in the context of tissue repair, is
an important future direction. The question of how CRT exits
the cell to exert the positive effects on wound repair is an
open question. Certainly, as injury to tissues induces cell
death, CRT would be passively released as a normal
requirement for wound repair. In addition, CRT is released
from neutrophils upon their activation and from cytotoxic
lymphocytes upon association with target cells (Burns et al.,
1992; Dupuis et al., 1993; Andrin et al., 1998; Cho et al.,
1999). Separately, it was also shown that CRT is a cell surface
receptor on neutrophils that promotes signaling via a G-
protein for activation of these cells, as evidenced by the
generation of superoxide anion (Cho et al., 1999). In this
context, the oxidative stress associated with injury, likewise,
causes mitochondrial release of reactive oxygen species and
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Figure 3. CRT induces migration of mouse fibroblasts using the scratch plate
wound assay. Mouse 3T3 cells were seeded in 12-well tissue culture plates in
DMEM, high glucose, and 10% calf serum. When the cells were 60–70%
confluent, serum-free media was added, and after 16–24 hours, the cells were
wounded using a 200 ml pipette tip to scrape and remove cells in a straight
line through the center of the plate. The cells were treated with increasing
concentrations of CRT, containing 3 mM calcium in media, and examined for
migration over the wounded area at 24 and 48 hours. The plates were
photographed and the area remaining uncovered by the cells at 48 hours was
compared to the original free space (0 hour¼ 0% of the total area). The areas
were traced and captured using Adobe Photoshop and the values obtained by
National Institute of Health Image Analysis software were converted to
percent wound closure. CRT without calcium induced minimal migration.
All treatments were performed in duplicate (n¼ 5 experiments). The results
showed that CRT maximally induces optimal wound closure of 36% at 50 pg/
ml. EGF (10 ng/ml) was used as a positive control inducing 36% wound
closure as well. The x axis is labeled in pg/ml.
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ER stress, thereby causing CRT to upregulate the production
of protective proteins (Bedard et al., 2005). CRT has a
profound effect on altering the total cellular levels of
phosphotyrosine directed from within the ER (Burridge and
Fath, 1989; Burridge et al., 1992; Burridge and Chrzanowska-
Wodnicka, 1996; Daniel and Reynolds, 1997; Schneider
et al., 1998; Fadel et al., 1999, 2001; Burridge, 2005). As
such, an effect on general signaling mechanisms involved in
receptor activation for both migration/adhesion and pro-
liferation may be important in the dynamic stochastic events
required for wound repair.
We show that CRT exerts positive biological effects on
both epidermal and dermal healing processes promoting an
accelerated time to wound closure and an increased amount
of highly cellular granulation tissue. Specifically, the in vitro
and in vivo data purport effects of CRT on migration of cells
into the wound, proliferation of cells to populate the wound,
production of extracellular matrix for remodeling the wound,
and evenly dispersed collagen to possibly lessen scarring. In
addition, critical to wound repair, the removal of dead cells is
a CRT-dependent process. This finding suggests a potential
role for CRT in the uptake of bacteria to lessen infection. With
this multifactorial effect of CRT on wound healing, we
propose that CRT treatment may have therapeutic benefit to
patients, such as diabetics with severe to delayed wound
healing.
NOTE ADDED IN PROOF
Recent experiments show that human keratinocytes and
fibroblasts migrated to a concentration gradient of calreti-
culin (CRT) using ChemoTx chambers (8.0 mm, membranes;
Neuroprobe) with optimal doses of 10 pg/ml (18-fold
increase over control) and 10 ng/ml (10-fold increase over
control) in keratinocytes (n¼3) and fibroblasts (n¼ 5),
respectively. These experiments show that CRT induces
directed migration of human keratinocytes and fibroblasts.
It is notable that similar optimal concentrations of CRT
induced non-directed migration using the scratch plate assay,
as described herein.
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